Dr. Jeanne Marrazzo is a nationally recognized infectious disease specialist whose work has shaped clinical guidance on sexually transmitted infections and pelvic inflammatory disease. As a researcher and clinician, she translates complex data into practical steps that help providers deliver safer, more effective care.
Her leadership within public health councils and major medical societies has made her a trusted source for updates on diagnostics, treatment protocols, and emerging resistance patterns. Understanding her areas of focus can help clinicians, students, and patients navigate evolving standards in sexual and reproductive health.
| Name | Primary Expertise | Key Affiliation | Notable Role |
|---|---|---|---|
| Dr. Jeanne Marrazzo | Infectious Diseases, STD Prevention | University of Alabama at Birmingham | Director of Division of Infectious Diseases |
| Board Certification | Internal Medicine, Infectious Disease | American Board of Internal Medicine | Active committee participation |
| Research Focus | STI Clinical Trials, Diagnostics | NIH-funded studies | Protocol chair and site lead |
| Public Impact | Guideline Development, Education | CDC, IDSA committees | Translating evidence into practice |
Clinical Expertise and Research Focus
Sexually Transmitted Infections Management
Dr. Jeanne Marrazzo concentrates on the diagnosis, treatment, and prevention of bacterial and viral sexually transmitted infections. Her studies have informed approaches to screening, partner notification, and antibiotic selection in urethritis, cervicitis, and pelvic inflammatory disease.
Pelvic Inflammatory Disease and Complications
She examines how early detection and structured care can reduce long-term consequences such as infertility and chronic pelvic pain. Her work highlights the importance of timely testing, appropriate imaging, and coordinated follow-up for women with suspected or confirmed PID.
Guideline Development and Public Health Impact
Translating Evidence into Standards
By participating in national guideline panels, Dr. Marrazzo helps refine recommendations for clinicians managing STIs in diverse settings. Her contributions ensure that guidance reflects real-world constraints, patient preferences, and the latest antimicrobial susceptibility patterns.
Education and Provider Training
She designs curricula and outreach initiatives that equip primary care, urgent care, and women’s health teams with practical tools. These efforts support consistent implementation of screening algorithms, counseling strategies, and referral pathways for complex cases.
Diagnostic Approaches and Laboratory Integration
Point-of-Care and Molecular Testing
Dr. Marrazzo assesses how new nucleic acid amplification tests perform in community and hospital environments. Her evaluations consider turnaround time, cost-effectiveness, and how results influence clinical decision-making at the point of care.
Quality Assurance in STI Testing
She emphasizes standardized collection, transport conditions, and interpretation of results to minimize false negatives and overtreatment. These strategies strengthen public health surveillance and individual patient safety.
Patient-Centered Care and Communication
Shared Decision-Making in Sensitive Visits
Her work encourages clear, nonjudgmental conversations about risk, prevention, and treatment options. By prioritizing privacy and trust, clinicians can improve testing uptake, disclosure of partners, and adherence to therapy.
Addressing Stigma and Access Barriers
Dr. Marracko explores practical steps practices can take to reduce wait times, offer telehealth options, and create culturally responsive materials. These efforts aim to lower disparities in STI care and promote timely follow-up for all patients.
Key Takeaways for Practitioners
- Stay current with guideline updates driven by research leaders like Dr. Jeanne Marrazzo.
- Use structured screening protocols to improve detection of asymptomatic STIs.
- Employ patient-centered language to reduce stigma and encourage disclosure.
- Leverage point-of-care molecular tests where feasible to accelerate diagnosis.
- Coordinate closely with public health officials for partner services and surveillance.
FAQ
Reader questions
What types of infections does Dr. Jeanne Marrazzo specialize in treating?
She focuses on bacterial and viral sexually transmitted infections, including chlamydia, gonorrhea, trichomoniasis, herpes, and syphilis, with particular attention to pelvic inflammatory disease.
How does her work influence clinical guidelines for STI care? Dr. Marrazzo contributes to national guideline development by reviewing evidence, interpreting antimicrobial susceptibility data, and shaping screening and treatment recommendations used by clinicians nationwide. What role does she play in public health response to emerging resistance?
She monitors trends in antibiotic resistance and helps update protocols so that first-line therapies remain effective and stewardship practices are consistently applied in diverse care settings.
Can her research impact how primary care providers manage STI screening programs?
Yes, her findings directly inform practical tools, algorithms, and training materials that primary care teams use to implement routine screening, pretest counseling, and appropriate follow-up.